Alexandre de Mendonça Selected Research

Alexandre de Mendonça Research Topics

25	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2007
19	Cognitive Dysfunction 01/2022 - 01/2004
18	Frontotemporal Dementia (Semantic Dementia) 08/2022 - 01/2013
15	Dementia (Dementias) 01/2022 - 09/2006
8	Atrophy 01/2022 - 02/2015
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 12/2007
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 01/2017
4	Parkinson Disease (Parkinson's Disease) 01/2017 - 12/2007
2	Disease Progression 01/2022 - 12/2019
2	Amyloid Plaque 01/2022 - 01/2018
2	Multiple Sclerosis 01/2017 - 12/2007
2	Amyloidosis 01/2016 - 02/2015
2	Nervous System Diseases (Neurological Disorders) 12/2007 - 03/2003
1	Gliosis 01/2022
1	Hearing Loss (Hearing Impairment) 09/2021
1	Tinnitus 09/2021
1	Cerebral Cortical Thinning 01/2021
1	Genetic Risk Score 01/2021
1	Tauopathies 11/2019
1	Neurobehavioral Manifestations 01/2018
1	Memory Disorders (Memory Loss) 01/2018
1	Neuroinflammatory Diseases 01/2017
1	Headache (Headaches) 02/2016
1	Back Pain (Backache) 02/2016
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2016
1	Disease Susceptibility (Diathesis) 09/2014
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 09/2014
1	Primary Progressive Aphasia 01/2012
1	Brain Injuries (Brain Injury) 12/2007
1	Stroke (Strokes) 12/2007
1	Huntington Disease (Huntington's Disease) 12/2007
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 09/2006
1	Hyponatremia 09/2006
1	Hyperthyroidism 09/2006
1	Renal Insufficiency (Renal Failure) 09/2006

23	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2014
13	Amyloid (Amyloid Fibrils)IBA 01/2022 - 02/2015
6	ProgranulinsIBA 08/2022 - 01/2013
4	GranulinsIBA 01/2022 - 01/2021
4	Apolipoproteins E (ApoE)IBA 01/2022 - 05/2015
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 08/2022 - 01/2017
3	Caffeine (No Doz)FDA LinkGeneric 01/2010 - 01/2010
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2017
2	sortilinIBA 01/2018 - 01/2016
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2018 - 01/2016
2	IronIBA 10/2015 - 04/2014
1	antineoplaston A10 (A 10)IBA 01/2022
1	neuronal pentraxinIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	tau Proteins (tau Protein)IBA 01/2022
1	sharpinIBA 01/2021
1	Biological ProductsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2018
1	T-Cell Intracellular Antigen-1IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	Nonsense Codon (Nonsense Mutation)IBA 09/2017
1	ImmunosorbentsIBA 01/2016
1	EnzymesIBA 01/2016
1	Phospholipases (Phospholipase)IBA 12/2015
1	Messenger RNA (mRNA)IBA 10/2015
1	Pemetrexed (MTA)FDA Link 02/2015
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	ElementsIBA 08/2011
1	LigandsIBA 12/2007
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 12/2007
1	Adenosine (Adenocard)FDA LinkGeneric 12/2007
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2007
1	CholesterolIBA 09/2006
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2003

1	Hearing Aids (Hearing Aid) 09/2021
1	Precision Medicine 11/2019
1	Punctures 02/2016
1	Long-Term Care 07/2013
1	Speech Therapy (Therapy, Speech) 01/2012
1	Activities of Daily Living (ADL) 01/2004